« Previous
Next »
Urologic Oncology: Seminars and Original Investigations
Volume 29, Issue 6
, Pages 614-623
, November 2011
Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma
References
- Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy. Urology. 2002;60:851–854
- Diagnostic utility of a p63/α-methyl coenzyme A racemase (p504s) cocktail in ambiguous lesions of the prostate upon needle biopsy. BJU Int. 2006;97:1109–1115
- Comparison of the basal cell-specific markers, 34βE12, and p63, in the diagnosis of prostate cancer. Am J Surg Pathol. 2002;26:1161–1168
- . A subset of prostate basal cells lacks the expression of corresponding phenotypic markers. Pathol Res Pract. 2006;202:651–662
- . Routine immunohistochemical staining for high-molecular weight cytokeratin 34-β and α-methylacyl CoA racemase (P504S) in postirradiation prostate biopsies. Mod Pathol. 2006;19:287–290
- . Benign mimickers of prostatic adenocarcinoma. Mod Pathol. 2004;17:328–348
- . α-Methylacyl CoA racemase (P504S): Overview and potential uses in diagnostic pathology as applied to prostate needle biopsies. Am J Clin Pathol. 2003;56:892–897
- . Effect of formalin fixation and epitope retrieval techniques on antibody 34βE12 immunostaining of prostatic tissues. Mod Pathol. 1999;12:472–478
- . Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy. Mod Pathol. 2004;17:307–315
- . Diagnosis of adenocarcinoma in prostate needle biopsy tissue. J Clin Pathol. 2007;60:35–42
- . Validation of cytokeratin 5/6 as an effective substitute for keratin 903 in the differentiation of benign from malignant glands in prostate needle biopsies. Histopathology. 2002;41:35–41
- Cytometric analysis of Fas and Bcl-2 expression in normal prostatic epithelium and prostate cancer. Urol Oncol. 2000;5:149–154
- How often does α-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?. Am J Surg Pathol. 2004;28:239–243
- . Basic and clinical biostatistics. New York: Lange Medical Books/McGraw Hill; 2004;
- . Categorical data analysis. New Jersey: John Wiley and Sons, Inc.; 2002;
- Diagnostic utility of a p63/α-methyl-CoA-racemase (p504s) cocktail in atypical foci in the prostate. Mod Pathol. 2004;17:1180–1190
- . Monoclonal antibodies to human intermediate filament proteins (II. Distribution of filament proteins in normal human tissues). Am J Pathol. 1984;114:309–321
- P504S/α-methylacyl-CoA racemase: A useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol. 2002;26:1169–1174
- . Best practice in diagnostic immunohistochemistry: Prostate carcinoma and its mimics in needle core biopsies. Arch Pathol Lab Med. 2008;132:1388–1396
- Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch. 2003;443:122–132
- Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: A study with logistic regression analysis. Am J Surg Pathol. 2001;25:43–50
- . Keratin expression in human tissues and neoplasms. Histopathology. 2002;40:403–439
- Distinguishing atrophy and high-grade prostatic intraepithelial neoplasia from prostatic adenocarcinoma with and without previous adjuvant hormone therapy with the aid of cytokeratin 5/6. Am J Clin Pathol. 2003;120:368–376
- . P63 and P73: p53 mimics, menaces, and more. Nat Rev Mol Cell Biol. 2000;1:199–207
- . Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Mod Pathol. 2002;15:1302–1308
- p63 Expression profile in normal and malignant prostate epithelial cells. Anticancer Res. 2002;22:3819–3825
- p63 Protein expression is rare in prostate adenocarcinoma: Implications for cancer diagnosis and carcinogenesis. Urology. 2001;58:619–624
- p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol. 2000;157:1769–1775
- Usefulness of basal cell cocktail (34βE12 + p63) in the diagnosis of atypical prostate glandular proliferations. Am J Clin Pathol. 2004;122:517–523
- Cytogenetic, molecular, biological, and clinical study of B-cell lymphomas with 14;18 translocation in Japanese patients. Leukemia. 1991;5:1069–1075
- Bcl-2 correlates with tumor ploidy and nuclear morphology in early stage prostate carcinoma (A fine needle aspiration biopsy study). Pathol Res Pract. 2001;197:487–492
- Usefulness of bcl-2 expression as a new basal cell marker in prostatic pathology [Abstract]. Acta Urol Esp. 2006;30:345–352
- α-Methylacyl-CoA racemase (P504S)/34βE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy. Hum Pathol. 2007;38:332–341
- Expression of α-methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol. 2002;26:921–925
- P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. Am J Surg Pathol. 2002;26:1588–1596
- . Immunohistochemical stains for p63 and α-methylacyl-CoA racemase, vs. a cocktail comprising both, in the diagnosis of prostatic carcinoma: A comparison of the immunohistochemical staining of 430 foci in radical prostatectomy and needle biopsy tissue. Am J Surg Pathol. 2005;29:874–880
- . Immunohistochemistry in diagnostic surgical pathology of the prostate. Semin Diagn Pathol. 2005;22:88–104
- Small glandular proliferations on needle biopsies: Most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion. Am J Surg Pathol. 2005;29:874–880
☆ This study was supported by grant 2008.08.02.275 from Abant Izzet Baysal University.
PII: S1078-1439(09)00366-4
doi: 10.1016/j.urolonc.2009.11.013
© 2011 Elsevier Inc. All rights reserved.
« Previous
Next »
Urologic Oncology: Seminars and Original Investigations
Volume 29, Issue 6
, Pages 614-623
, November 2011
